Baltimore, MD, United States of America

Charles David Pauza

This inventor holds 35 USPTO granted patents and 23 published patent applications and 3 EPO patents, primarily in Immunotherapy Research. Top assignees: American Gene Technologies International Inc., Other. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles David Pauza. Retrieved from https://idiyas.com/inventor/charles-david-pauza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 238(Granted Patents)


Location History:

  • Baltimore, MD (US) (2017 - 2023)
  • Rockville, MD (US) (2020 - 2024)

Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
HIV Immunotherapy
Gamma-Delta T-Cells
Viral Vectors
Tumor Cytotoxicity
Regulatory RNA
Cancer Treatment
Pre-Immunization
Parkinson's Disease
Combination Vectors
Cell Resistance
35 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Charles David Pauza

Introduction

Charles David Pauza, a distinguished inventor based in Baltimore, MD, has made significant strides in the field of immunotherapy. With a remarkable portfolio of 27 patents, Pauza has dedicated his career to developing innovative solutions aimed at combating various health challenges, particularly HIV.

Latest Patents

Pauza's recent patents highlight his commitment to advancing medical science. One of his notable innovations is centered on the "Methods of producing cells resistant to HIV infection," which focuses on immunotherapy techniques designed to prevent HIV infection in HIV-negative individuals. This invention outlines methods for creating resistant cells and administering therapies to enhance immune responses.

Additionally, Pauza's patent on "HIV pre-immunization and immunotherapy" delves into the treatment and prevention of HIV. This innovative approach involves the enrichment of HIV-specific CD4 T cells both in vivo and ex vivo, incorporating therapies to bolster these crucial immune cells further.

Career Highlights

Throughout his career, Pauza has worked with leading organizations such as American Gene Technologies International Inc., where he has contributed to groundbreaking research and development in the field of gene therapy and immunotherapy. His extensive experience in this area underscores his role as a forward-thinking inventor.

Collaborations

In his journey, Pauza has collaborated with visionary colleagues, including Tyler Lahusen and Haishan Li, who have shared his passion for advancing medical innovations. Their collective efforts in research and development have aimed at creating effective solutions for immune-related challenges.

Conclusion

Charles David Pauza represents a prime example of how dedication and innovative thinking can lead to significant advancements in healthcare. His impressive array of patents and collaborations demonstrates his invaluable contributions to the fight against HIV through immunotherapy. As he continues to develop new methodologies and innovations, Pauza's work will undoubtedly leave a lasting impact on the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…